SpaceX Has Already Dropped 30% From Its Peak: Time To Buy Below $165?

SpaceX’s IPO-era stock has fallen ~30% from a mid-June peak near $225 to the mid-$150s/low $160s, but it still trades at >100x trailing sales versus Nvidia (~19x), Microsoft (~9x), and Amazon (~3.5x). Despite an average July 3 price target around $188 implying ~17.5% upside, the article argues valuation is too stretched and advises waiting for more clarity—especially as IPO underwriter “quiet period” ends on July 7 and bank analysts may drive further repricing.

Analysis

The real market mechanism here is not “bad news,” it’s multiple fragility: when a name already trades on the expectation of many years of compounding, any incremental disappointment gets amplified because there is little valuation cushion. That makes SPCX vulnerable to a classic post-IPO unwind where marginal buyers disappear after the initial scarcity premium fades. By contrast, proven cash-generative growth leaders like NVDA, MSFT, and AMZN look relatively more attractive to factor allocators once the market re-prices duration risk.

The near-term catalyst is the end of the quiet period, which can create a tactical pop if sell-side coverage comes in supportive, but that effect is usually short-lived unless it is paired with fresh evidence on launch cadence, margin structure, or monetization that changes forward estimates. Over 1-3 months, the key risk is that analyst targets become a liquidity event rather than a valuation floor; if the stock cannot hold the low-$160s after coverage resumes, the next leg can be a sharp de-rating. Over 6-18 months, the thesis only breaks if the company repeatedly proves it can sustain hypergrowth without forcing the market to re-rate the revenue multiple downward.

The consensus is likely underestimating how little fundamental bad news is needed to justify a lower price in a 100x-sales stock. A 30% drawdown can still leave the shares expensive enough that the market keeps demanding “perfect execution,” which is a bad setup for a name with long-duration operational and regulatory risk. The contrarian setup is that this is not yet a value opportunity; it is more likely a test of how much speculative premium the market is willing to pay for optionality versus actual operating proof. If the stock reclaims the prior highs on real estimate revisions, the bear case weakens; if it stalls below that range, the downtrend likely resumes.

Key Decisions for Investors

• Use the July 7 analyst-initiation window as a tactical fade point: if SPCX rallies 5-10% on favorable coverage, look to short or buy put spreads for a 1-3 month hold, with invalidation on a sustained move back above the prior high zone.
• Prefer a relative-value long basket of NVDA/MSFT/AMZN versus any speculative space exposure, including SPCX and listed space proxies like RKLB/ASTS/LUNR; the trade benefits if the market keeps rotating from narrative-duration into proven cash-flow duration over the next 1-3 months.
• Do not add fresh long exposure into the first week of post-quiet-period coverage unless there is a material revision to forward revenue or margin assumptions; the base case is a sentiment-driven pop that fades once the incremental buyers are exhausted.
• Set an alert on SPCX losing the low-$150s: that would suggest the post-IPO support has been fully worked off and could open a deeper de-rating toward the next visible support level; conversely, a clean move back above the prior high would falsify the near-term short thesis.